These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 1753383)

  • 1. Effect of age on the kinetics of the binding of iodocyanopindolol to a membrane preparation of rat lungs.
    Fraeyman N; Vanscheeuwijck P
    J Recept Res; 1991; 11(6):985-99. PubMed ID: 1753383
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Thermodynamic study of iodocyanopindolol beta-adrenoceptors interactions with rat lung and cerebral cortex.
    Morin D; Zini R; Brunner F; Sebille B; Tillement JP
    J Recept Res; 1983-1984; 3(6):773-90. PubMed ID: 6090659
    [TBL] [Abstract][Full Text] [Related]  

  • 3. (+/-)[125Iodo] cyanopindolol, a new ligand for beta-adrenoceptors: identification and quantitation of subclasses of beta-adrenoceptors in guinea pig.
    Engel G; Hoyer D; Berthold R; Wagner H
    Naunyn Schmiedebergs Arch Pharmacol; 1981; 317(4):277-85. PubMed ID: 6119625
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Specific non-beta-adrenergic binding sites for 125I-iodocyanopindolol in myocardial membrane preparations: a comparative study between human, rat, and porcine hearts.
    Bjørnerheim R; Golf S; Hansson V
    Cardiovasc Res; 1991 Sep; 25(9):764-73. PubMed ID: 1666020
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ligand binding properties of putative beta 3-adrenoceptors compared in brown adipose tissue and in skeletal muscle membranes.
    Sillence MN; Moore NG; Pegg GG; Lindsay DB
    Br J Pharmacol; 1993 Aug; 109(4):1157-63. PubMed ID: 8104645
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Binding of propranolol and iodocyanopindolol to isolated cells, homogenates and plasma membranes of rat liver, lung, kidney and heart.
    Zini R; Gault I; Ledewyn S; D'Athis P; Tillement JP
    Biochem Pharmacol; 1983 Nov; 32(22):3375-80. PubMed ID: 6316980
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Beta-adrenoceptors in kidney tubules of spontaneously hypertensive and normotensive rats.
    Struyker-Boudier HA; Vervoort-Peters LH; Rousch MJ; Smits JF; Thijssen HH
    Life Sci; 1986 Jan; 38(2):137-45. PubMed ID: 3003473
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lung tissue binding of iodobenzyl-propanediamine: involvement of beta-adrenergic receptors.
    Paci A; Ciarimboli G; Miniati M; Cocci F; Piras F; Pistolesi M
    J Pharm Biomed Anal; 1989; 7(12):1467-72. PubMed ID: 2562314
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Selectivity of bunitrolol for beta 1- and beta 2-adrenergic receptors and 5HT1B-receptors: assessment by biphasic Scatchard plots and biphasic displacement curve analysis with 125I-iodocyanopindolol and 3H-CGP12177.
    Tsuchihashi H; Nagotomo T; Imai S
    Jpn J Pharmacol; 1989 Jun; 50(2):93-100. PubMed ID: 2570175
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibition of (-) [125I]-iodocyanopindolol binding to rat lung beta adrenoceptors by uremic plasma ultrafiltrates.
    Bree F; Souchet T; Baatard R; Fontenaille C; Lhoste F; Tillement JP
    Biochem Pharmacol; 1987 Oct; 36(19):3121-5. PubMed ID: 2822046
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Adrenergic agonists do not compete with the antagonist (-)3-[125I]iodocyanopindolol for binding to rat pleural or peritoneal mast cell adrenergic receptor.
    Botana LM
    Gen Pharmacol; 1987; 18(3):263-7. PubMed ID: 2883071
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identical binding properties of (+/-)- and (-)-125Iodocyanopindolol to beta 2-adrenoceptors in intact human lymphocytes.
    O'Hara N; Brodde OE
    Arch Int Pharmacodyn Ther; 1984 Nov; 272(1):24-39. PubMed ID: 6097199
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Application of [125I]iodocyanopindolol to measure 5-hydroxytryptamine1B receptors in the brain of the rat.
    Offord SJ; Ordway GA; Frazer A
    J Pharmacol Exp Ther; 1988 Jan; 244(1):144-53. PubMed ID: 3335996
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Atypical responses of rat ileum to pindolol, cyanopindolol and iodocyanopindolol.
    Hoey A; Jackson C; Pegg G; Sillence M
    Br J Pharmacol; 1996 Feb; 117(4):712-6. PubMed ID: 8646418
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Receptor-independent sequestration of beta-adrenergic ligands by alveolar type II cells.
    Fabisiak JP; Rannels SR; Vesell ES; Rannels DE
    Am J Physiol; 1986 Jun; 250(6 Pt 1):C871-9. PubMed ID: 3013016
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Labelling of rat brain beta-adrenoceptors: (3H)CGP-12177 or (125I)iodocyanopindolol?
    Morin D; Zini R; Urien S; Sapena R; Tillement JP
    J Recept Res; 1992; 12(3):369-87. PubMed ID: 1354747
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characterization of propranolol-resistant (-)-[125I]-cyanopindolol binding sites in rat soleus muscle.
    Roberts SJ; Molenaar P; Summers RJ
    Br J Pharmacol; 1993 Jun; 109(2):344-52. PubMed ID: 8102926
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characterization of the 5-HT1B recognition site in rat brain: binding studies with (-)[125I]iodocyanopindolol.
    Hoyer D; Engel G; Kalkman HO
    Eur J Pharmacol; 1985 Nov; 118(1-2):1-12. PubMed ID: 3002805
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Three binding sites of 125I-iodocyanopindolol, i.e. beta 1, beta 2-adrenergic and 5HT1B-serotonergic receptors in rat brain determined by the displacement and Scatchard analysis.
    Tsuchihashi H; Nagatomo T; Imai S
    J Pharmacobiodyn; 1989 Sep; 12(9):509-16. PubMed ID: 2559184
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Binding of [125I]iodocyanopindolol by rat harderian gland crude membranes: kinetic characteristics and day-night variations.
    Harmouch A; Osuna C; Rafii-el-Idrissi M; Calvo JR; Guerrero JM
    Biosci Rep; 1996 Oct; 16(5):369-77. PubMed ID: 8913527
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.